Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
PRIORITY PRESS - Annual General Meeting of the Canadian Society of Nephrology
Exploring B-cell Targeted Therapy in the Management of Glomerulonephritis
Montreal, Québec / April 24-28, 2013
Montreal - Treatment of glomerulonephritis has long been dependent on the use of steroids plus cytotoxic or antiproliferative drugs. With the success of therapeutic monoclonal agents in other autoimmune diseases, their use in...
MEDICAL FRONTIERS - 48th Annual Meeting of the European Association for the Study of the Liver
New Protease Inhibitor Data Support Large Leap in Hepatitis C Virus Control
Amsterdam, The Netherlands / April 24-28, 2013
Amsterdam - In the rapidly evolving field of hepatitis C virus (HCV), protease inhibitors (PIs) are poised to provide additional incremental increases to sustained virologic remission (SVR) rates in difficult cases. Since their...
PHYSICIAN PERSPECTIVE - Get with the PROTOCOL - A Regional Perspective on the Evidence and Resulting Changes in ACS Protocol
Centre de santé et de services sociaux de Chicoutimi
April 2013
Reviewed and edited by: Tomás Cieza, MDCardiologistCentre de santé et de services sociaux de ChicoutimiChicoutimi, QuebecPierre Bélisle, MDCardiologistCentre de santé et de services sociaux de...
PRIORITY PRESS - 8th Congress of the European Crohn’s and Colitis Organisation
The Potential of IV Iron Treatment in IBD Patients with Iron Deficiency Anemia
Vienna, Austria / February 14-16, 2013
Vienna - Anemia is the most common complication of inflammatory bowel disease (IBD), iron deficiency anemia (IDA) being the most prevalent cause. Correction of iron deficiency and IDA in IBD patients reduces the associated fatigue and...
PRIORITY PRESS - AMMI Canada - CACMID Annual Conference
New NACI Guidelines for Pneumococcal Disease Prevention in High-Risk Adults
Québec City, Quebec/ April 4-6, 2013
Québec City - Prevention of pneumococcal and other vaccine-preventable diseases is challenging in patients with immune deficiency. Vaccines are less immunogenic in this population. Many patients have not had recommended...
PHYSICIAN PERSPECTIVE - Get with the PROTOCOL - A Regional Perspective on the Evidence and Resulting Changes in ACS Protocol
Centre hospitalier universitaire de Québec
April 2013
Reviewed and edited by: Patrick Béliveau, MD, CSPQ, FRCPCCardiologueHôtel Dieu de Québec-CHU de QuébecQuébec, Québec IntroductionThe management of acute coronary syndromes (ACS) has recently been...
PHYSICIAN PERSPECTIVE - Get with the PROTOCOL - A Regional Perspective on the Evidence and Resulting Changes in ACS Protocol
Centre hospitalier universitaire de Sherbrooke
April 2013
Reviewed and edited by: Michel Nguyen, MD, FRCPCInterventional CardiologyCentre hospitalier universitaire de SherbrookeProfessor of MedicineUniversité de SherbrookeSherbrooke, Quebec IntroductionAntiplatelet therapy in the...
PRIORITY PRESS - Canadian Digestive Disease Week (CDDW) and the Annual CASL Winter Meeting
Probiotics in the Treatment of Irritable Bowel Syndrome
Victoria, B.C. / March 1-4, 2013
Victoria - Irritable bowel syndrome (IBS) is a persistent condition of uncertain etiology, for which definitive treatments are lacking. Some traditional therapies, such as increasing dietary fibre, are not supported by recent clinical data....
MEDI-NEWS - Head-to-Head Comparisons of Biologics in Rheumatoid Arthritis: Closing the Data Gap
Based on Arthritis Rheum 2012;64(12):3850-5; Arthritis Rheum 2013:65(1):28-38; The Lancet Published online March 18, 2013.
March 2013
Over the past decade, the biologics have significantly enhanced the management of patients with rheumatoid arthritis (RA) and continue to do so with the emergence of new biologics with different modes of action. Until recently, no...